Natural products targeting the ATR-CHK1 signaling pathway in cancer therapy
Cancer is one of the most severe medical conditions in the world, causing millions of deaths each year. Chemotherapy and radiotherapy are critical for treatment approaches, but both have numerous adverse health effects. Furthermore, the resistance of cancerous cells to anticancer medication leads to...
Main Authors: | Salman Ahmed, Waqas Alam, Michael Aschner, Khalaf F. Alsharif, Ashraf Albrakati, Luciano Saso, Haroon Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222011866 |
Similar Items
-
Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
by: Patrycja Gralewska, et al.
Published: (2020-04-01) -
Prospects for the Use of ATR Inhibitors to Treat Cancer
by: Scott H. Kaufmann, et al.
Published: (2010-04-01) -
Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance
by: Laure David, et al.
Published: (2017-09-01) -
Olaparib-Resistant <i>BRCA2</i><sup>MUT</sup> Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival
by: Łukasz Biegała, et al.
Published: (2023-03-01) -
PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality—An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness
by: Patrycja Gralewska, et al.
Published: (2020-12-01)